Skip to content
Menu

Syndax Pharmaceuticals, Inc. SNDX

Full chart Compare
Set alert

Price alert · SNDX

All alert types
9.13 USD -0.32 (-3.39%)

Regular-session close

9.20 +0.07 +0.77%

After hours · Nov 16, 4:00 PM ET

9.06 Day range 9.48
9.06 52-week range 25.59
YTD
-56.54%
1 year
-45.07%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Gross Profit$165.38MNet Loss$285.42MCost of Revenue$6.97MExpenses$450.80MSelling, General & Admin$179.68MResearch & Development$258.78MOther Expenses$12.34MRevenue$172.35MNet Product Revenues$124.84MCollaboration revenue$42.37MMilestone Revenue$5.14M

Latest period ending Dec 31, 2025 · select a line to chart its full history

SNDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
172.35M23.68M00139.71M
165.38M22.85M00139.71M
-273.08M-339.67M-229.95M-151.76M26.22M
-285.42M-318.76M-209.36M-149.34M24.93M
-3.29-3.72-2.98-2.460.46
SNDX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
135.03M154.30M295.61M74.47M222.08M
529.71M724.82M612.88M497.24M449.66M
465.08M436.69M58.68M29.79M41.29M
345.43M345.74M1.64M1.16M20.97M
64.63M288.12M554.20M467.45M408.37M
SNDX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-322.98M-274.90M-160.60M-133.68M29.13M
290.04M-219.78M117.61M-186.19M-40.87M
13.68M353.37M264.13M172.25M118.46M
-187.00K00225.00K-129.00K
-19.27M-141.31M221.14M-147.61M106.72M